The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 03, 2015
Filed:
Sep. 07, 2007
Applicants:
Herve DE Hemptinne, Rixensar, BE;
Michel Duchene, Rixensart, BE;
Anne Mary, Rixensart, BE;
Marc Sonveaux, Rixensart, BE;
Inventors:
Herve De Hemptinne, Rixensar, BE;
Michel Duchene, Rixensart, BE;
Anne Mary, Rixensart, BE;
Marc Sonveaux, Rixensart, BE;
Assignee:
GlaxoSmithKline Biologicals S.A., Rixensart, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/295 (2006.01); A61K 39/13 (2006.01); A61K 39/116 (2006.01); A61K 39/00 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/13 (2013.01); A61K 39/0018 (2013.01); A61K 39/12 (2013.01); A61K 2039/5252 (2013.01); C12N 2770/32634 (2013.01); C12N 2770/2671 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55544 (2013.01); C12N 2730/10134 (2013.01);
Abstract
The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain adequate or improved level of protection against polio.